WGU D116 Advanced Pharmacology OA - Practice Questions &
Guide Exam Questions and Answers with Explanation (Latest
): Most Comprehensive to Pass the Exam, 100%
Verified - UPDATED.
This comprehensive objective assessment evaluates graduate nursing students' mastery of advanced
pharmacotherapeutics across the lifespan. It emphasizes clinical decision-making, pharmacokinetic and
pharmacodynamic principles, pharmacogenomics, and safe prescribing practices in diverse patient populations.
The exam aligns with WGU D116 course outcomes and current national standards. It contains 50 multiple-choice
questions, each with four distractors and a fully worked rationale that explains why the keyed answer is correct.
Questions are organized into clearly labelled sections that mirror the major content areas of the course. Targeted
learning outcomes include: Apply pharmacokinetic and pharmacodynamic principles to optimize drug therapy in
complex patients.; Integrate pharmacogenomic data to individualize medication selection and dosing.; Evaluate
drug therapy regimens for safety, efficacy, and potential interactions across special populations.. Every item has
been reviewed for clinical accuracy, current guidelines, and clarity so that students can study with confidence and
self-correct as they work through the bank. Use it as a high-yield review immediately before the exam, or as a
structured practice tool during the unit - the rationales double as concise teaching notes. The recommended
writing time is 2.5 hours, with a passing score of 80%. Aligned with Meets AACN Essentials and NCSBN
NCLEX-RN Test Plan standards for graduate nursing education. standards and reflects the question style
commonly seen on accredited program examinations. Students consistently achieving above the cut score on this
Section 1: General (Questions 1-50)
1 Which cytochrome P450 enzyme is most responsible for the metabolism of
clopidogrel to its active metabolite?
A) CYP3A4
B) CYP2C19
C) CYP2D6
D) CYP1A2
Answer: B
Rationale: Clopidogrel is a prodrug requiring bioactivation primarily by CYP2C19.
Genetic polymorphisms in CYP2C19 can lead to reduced antiplatelet effect.
CYP3A4, CYP2D6, and CYP1A2 play minor roles but are not the primary enzymes.
2 A patient with heart failure and reduced ejection fraction is prescribed
sacubitril/valsartan. Which concurrent medication requires immediate
discontinuation?
A) Carvedilol
B) Spironolactone
C) Lisinopril
D) Furosemide
,Answer: C
Rationale: Sacubitril/valsartan must not be used concomitantly with ACE inhibitors
due to increased risk of angioedema. A 36-hour washout period is required when
switching. Beta-blockers, aldosterone antagonists, and loop diuretics are safe and
often used together.
3 Which statement accurately describes the mechanism of action of SGLT2
inhibitors in type 2 diabetes?
A) They increase insulin secretion from pancreatic beta cells.
B) They reduce hepatic glucose production by activating AMPK.
C) They inhibit renal glucose reabsorption, promoting glycosuria.
D) They slow intestinal carbohydrate absorption by inhibiting alpha-glucosidase.
Answer: C
Rationale: SGLT2 inhibitors block sodium-glucose cotransporter 2 in the proximal
tubule, reducing glucose reabsorption and increasing urinary glucose excretion.
They do not directly stimulate insulin secretion or inhibit alpha-glucosidase. AMPK
activation is associated with metformin.
4 A patient on lithium therapy presents with coarse tremors, ataxia, and confusion.
Which condition most likely explains these findings?
A) Lithium toxicity
B) Serotonin syndrome
C) Neuroleptic malignant syndrome
D) Acute dystonia
Answer: A
Rationale: Coarse tremors, ataxia, and confusion are classic signs of lithium toxicity,
often precipitated by dehydration or drug interactions. Serotonin syndrome presents
with hyperreflexia and clonus; neuroleptic malignant syndrome includes rigidity and
hyperthermia; acute dystonia involves muscle spasms.
5 Which antibiotic requires therapeutic drug monitoring due to a narrow therapeutic
index and risk of nephrotoxicity?
A) Azithromycin
B) Vancomycin
C) Ceftriaxone
D) Levofloxacin
Answer: B
Rationale: Vancomycin has a narrow therapeutic index and can cause nephrotoxicity
, and ototoxicity, necessitating monitoring of trough levels. Azithromycin,
ceftriaxone, and levofloxacin generally do not require routine therapeutic drug
monitoring.
6 Which medication is a long-acting beta-2 agonist (LABA) approved for
maintenance therapy in asthma but not for acute bronchospasm?
A) Albuterol
B) Salmeterol
C) Ipratropium
D) Montelukast
Answer: B
Rationale: Salmeterol is a LABA indicated for long-term control of asthma, not for
acute relief. Albuterol is a short-acting beta-2 agonist for acute symptoms.
Ipratropium is an anticholinergic, and montelukast is a leukotriene modifier.
7 Which proton pump inhibitor (PPI) is most likely to interact with clopidogrel by
inhibiting CYP2C19?
A) Pantoprazole
B) Omeprazole
C) Rabeprazole
D) Esomeprazole
Answer: B
Rationale: Omeprazole is a strong inhibitor of CYP2C19 and can reduce clopidogrel
activation, decreasing its antiplatelet effect. Pantoprazole and rabeprazole have less
CYP2C19 inhibition. Esomeprazole also inhibits CYP2C19 but to a lesser extent
than omeprazole.
8 Which NSAID is most appropriate for a patient with a history of peptic ulcer
disease requiring anti-inflammatory therapy?
A) Indomethacin
B) Ketorolac
C) Celecoxib
D) Naproxen
Answer: C
Rationale: Celecoxib, a selective COX-2 inhibitor, has a lower risk of gastrointestinal
ulceration compared to nonselective NSAIDs. Indomethacin, ketorolac, and
naproxen inhibit both COX-1 and COX-2, increasing ulcer risk.
Guide Exam Questions and Answers with Explanation (Latest
): Most Comprehensive to Pass the Exam, 100%
Verified - UPDATED.
This comprehensive objective assessment evaluates graduate nursing students' mastery of advanced
pharmacotherapeutics across the lifespan. It emphasizes clinical decision-making, pharmacokinetic and
pharmacodynamic principles, pharmacogenomics, and safe prescribing practices in diverse patient populations.
The exam aligns with WGU D116 course outcomes and current national standards. It contains 50 multiple-choice
questions, each with four distractors and a fully worked rationale that explains why the keyed answer is correct.
Questions are organized into clearly labelled sections that mirror the major content areas of the course. Targeted
learning outcomes include: Apply pharmacokinetic and pharmacodynamic principles to optimize drug therapy in
complex patients.; Integrate pharmacogenomic data to individualize medication selection and dosing.; Evaluate
drug therapy regimens for safety, efficacy, and potential interactions across special populations.. Every item has
been reviewed for clinical accuracy, current guidelines, and clarity so that students can study with confidence and
self-correct as they work through the bank. Use it as a high-yield review immediately before the exam, or as a
structured practice tool during the unit - the rationales double as concise teaching notes. The recommended
writing time is 2.5 hours, with a passing score of 80%. Aligned with Meets AACN Essentials and NCSBN
NCLEX-RN Test Plan standards for graduate nursing education. standards and reflects the question style
commonly seen on accredited program examinations. Students consistently achieving above the cut score on this
Section 1: General (Questions 1-50)
1 Which cytochrome P450 enzyme is most responsible for the metabolism of
clopidogrel to its active metabolite?
A) CYP3A4
B) CYP2C19
C) CYP2D6
D) CYP1A2
Answer: B
Rationale: Clopidogrel is a prodrug requiring bioactivation primarily by CYP2C19.
Genetic polymorphisms in CYP2C19 can lead to reduced antiplatelet effect.
CYP3A4, CYP2D6, and CYP1A2 play minor roles but are not the primary enzymes.
2 A patient with heart failure and reduced ejection fraction is prescribed
sacubitril/valsartan. Which concurrent medication requires immediate
discontinuation?
A) Carvedilol
B) Spironolactone
C) Lisinopril
D) Furosemide
,Answer: C
Rationale: Sacubitril/valsartan must not be used concomitantly with ACE inhibitors
due to increased risk of angioedema. A 36-hour washout period is required when
switching. Beta-blockers, aldosterone antagonists, and loop diuretics are safe and
often used together.
3 Which statement accurately describes the mechanism of action of SGLT2
inhibitors in type 2 diabetes?
A) They increase insulin secretion from pancreatic beta cells.
B) They reduce hepatic glucose production by activating AMPK.
C) They inhibit renal glucose reabsorption, promoting glycosuria.
D) They slow intestinal carbohydrate absorption by inhibiting alpha-glucosidase.
Answer: C
Rationale: SGLT2 inhibitors block sodium-glucose cotransporter 2 in the proximal
tubule, reducing glucose reabsorption and increasing urinary glucose excretion.
They do not directly stimulate insulin secretion or inhibit alpha-glucosidase. AMPK
activation is associated with metformin.
4 A patient on lithium therapy presents with coarse tremors, ataxia, and confusion.
Which condition most likely explains these findings?
A) Lithium toxicity
B) Serotonin syndrome
C) Neuroleptic malignant syndrome
D) Acute dystonia
Answer: A
Rationale: Coarse tremors, ataxia, and confusion are classic signs of lithium toxicity,
often precipitated by dehydration or drug interactions. Serotonin syndrome presents
with hyperreflexia and clonus; neuroleptic malignant syndrome includes rigidity and
hyperthermia; acute dystonia involves muscle spasms.
5 Which antibiotic requires therapeutic drug monitoring due to a narrow therapeutic
index and risk of nephrotoxicity?
A) Azithromycin
B) Vancomycin
C) Ceftriaxone
D) Levofloxacin
Answer: B
Rationale: Vancomycin has a narrow therapeutic index and can cause nephrotoxicity
, and ototoxicity, necessitating monitoring of trough levels. Azithromycin,
ceftriaxone, and levofloxacin generally do not require routine therapeutic drug
monitoring.
6 Which medication is a long-acting beta-2 agonist (LABA) approved for
maintenance therapy in asthma but not for acute bronchospasm?
A) Albuterol
B) Salmeterol
C) Ipratropium
D) Montelukast
Answer: B
Rationale: Salmeterol is a LABA indicated for long-term control of asthma, not for
acute relief. Albuterol is a short-acting beta-2 agonist for acute symptoms.
Ipratropium is an anticholinergic, and montelukast is a leukotriene modifier.
7 Which proton pump inhibitor (PPI) is most likely to interact with clopidogrel by
inhibiting CYP2C19?
A) Pantoprazole
B) Omeprazole
C) Rabeprazole
D) Esomeprazole
Answer: B
Rationale: Omeprazole is a strong inhibitor of CYP2C19 and can reduce clopidogrel
activation, decreasing its antiplatelet effect. Pantoprazole and rabeprazole have less
CYP2C19 inhibition. Esomeprazole also inhibits CYP2C19 but to a lesser extent
than omeprazole.
8 Which NSAID is most appropriate for a patient with a history of peptic ulcer
disease requiring anti-inflammatory therapy?
A) Indomethacin
B) Ketorolac
C) Celecoxib
D) Naproxen
Answer: C
Rationale: Celecoxib, a selective COX-2 inhibitor, has a lower risk of gastrointestinal
ulceration compared to nonselective NSAIDs. Indomethacin, ketorolac, and
naproxen inhibit both COX-1 and COX-2, increasing ulcer risk.
